Uncategorized
New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises
On this week’s episode of “The Readout LOUD”: New hope for people living with Huntington’s disease, and a report card on RFK Jr.’s effort to remake health in America.
The Food and Drug Administration reversed its opposition to a closely watched gene therapy for Huntington’s disease, clearing a path for its maker, the biotech company UniQure, to file for U.S. approval. Joining us to discuss this new development and what it means for the Huntington’s community is Lauren Holder, a Huntington’s disease advocate who is living with the early stages of the disease.
On this week’s episode of “The Readout LOUD”: New hope for people living with Huntington’s disease, and a report card on RFK Jr.’s effort to remake health in America.
The Food and Drug Administration reversed its opposition to a closely watched gene therapy for Huntington’s disease, clearing a path for its maker, the biotech company UniQure, to file for U.S. approval. Joining us to discuss this new development and what it means for the Huntington’s community is Lauren Holder, a Huntington’s disease advocate who is living with the early stages of the disease.